Diagnosis and Classification of Systemic Sclerosis
- 10 February 2010
- journal article
- review article
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 40 (2) , 78-83
Abstract
As the diagnosis of systemic sclerosis (SSc) is generally suggested by the presence of Raynaud’s phenomenon followed by typical skin thickening associated with the presence of additional extracutaneous features, capillaroscopic abnormalities, and characteristic autoantibodies, the first classification criteria, published by the American Rheumatism Association in 1980, were based only on clinical and chest X-ray items. As a consequence, 10% to 20% of the patients did not meet these criteria. In 1988, an international consensus was reached resulting in the proposal of a new and more practical classification based on the judgment and clinical practice of an expert panel. This classification introduced the SSc nail fold capillaroscopy abnormalities (dilation and/or avascular areas) and specific antinuclear antibodies. Two subsets of SSc emerged from discussions: diffuse cutaneous SSc (dcSSc) and limited cutaneous SSc (lcSSc). The calcifications, Raynaud’s phenomenon, esophageal hypomotility, sclerodactyly, and telangiectasia (CREST) syndrome can be considered an lcSSc. In 2001, LeRoy and Medsger, realizing the shortcomings of the 1988 subsets in being too exclusive and taking advantage of increased experience with nail fold capillaroscopy and autoantibody determination, proposed criteria for an additional early or limited subset of SSc (lSSc), to supplement the previously recognized lcSSc and dcSSc forms. Patients with lSSc must have Raynaud’s phenomenon and SSc-specific nail fold capillary changes and/or SSc-specific autoantibodies. Some lSSc patients who have no cutaneous involvement but common SSc nail fold capillaroscopy abnormalities, specific antinuclear antibodies, and visceral involvement are sometimes called SSc sine scleroderma. Whether or not lSSc and SSc sine scleroderma are the same or two different subsets is currently not known.Keywords
This publication has 18 references indexed in Scilit:
- Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological studyAnnals of the Rheumatic Diseases, 2009
- Changes in causes of death in systemic sclerosis, 1972–2002Annals of the Rheumatic Diseases, 2007
- Scleroderma renal crisis: patient characteristics and long-term outcomesQJM: An International Journal of Medicine, 2007
- Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US populationArthritis & Rheumatism, 2003
- Evidence‐based guidelines for the use of immunologic tests: Anticentromere, Scl‐70, and nucleolar antibodiesArthritis Care & Research, 2003
- Predicting Mortality in Systemic SclerosisMedicine, 2002
- Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: Addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited sclerodermaArthritis & Rheumatism, 2001
- Systemic sclerosis sine scleroderma: Demographic, clinical, and serologic features and survival in forty-eight patientsArthritis & Rheumatism, 2000
- Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.1988
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980